John Cooper discusses Merck KGaA's bio-based solvents for lab analysis
1 report, 1 independent
Updated Oct 12
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
John Cooper discussed Merck KGaA's LiChrosolv® BioRenewable solvents during a SelectScience TechTalk on October 12, 2026. These solvents are bio-based and derived from renewable feedstocks. They deliver, on average, 25.9% lower CO₂ equivalents compared to conventional fossil-fuel-based alternatives.
From selectscience.net
Why it matters
The solvents are designed as drop-in replacements for high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) analysis. This allows laboratories to reduce solvent-related environmental impact without requiring changes to their analytical methods.
From selectscience.net
Who's involved
- John CooperDiscussed Merck KGaA's bio-based solvents during a TechTalk.
- Merck KGaAProvides bio-based solvents engineered for HPLC and LC-MS analysis.
Keep exploring
The entities involved
-
John Cooper
Australian tennis player
Nothing else this week.
-
Merck KGaA
German multinational science and technology company